Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’
Professor Larry Corey, principal researcher of the AMP studies, speaking at HIVR4P Two years ago, at the HIV Research for Prevention (HIVR4P) conference in Madrid, Professor Lynn Morris of the South African National Institute for Communicable Diseases made a prediction about the AMP (Antibody-Mediated Protection) studies. The two studies are the first large studies using injections every… Read More »